ArticleBMJ open2024

Trial to assess the tolerability of using felodipine to upregulate autophagy as a treatment of Huntington's disease (FELL-HD): a phase II, single-centre, open-label, dose-finding trial protocol.

Katie Andresen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.